Corneal Healing and Recovery of Ocular Crystallinity with a Dichloromethane Extract of Sedum dendroideum D.C. in a Novel Murine Model of Ocular Pterygium
Authors:
- Luiselva Torrescano-De LabraLLLuiselva Torrescano-De Labra
- Enrique Jiménez-FerrerEJEnrique Jiménez-Ferrer
- Brenda Hildeliza Camacho-DíazBrenda Hildeliza Camacho-Díaz
- Gabriela Vargas-VillaGVGabriela Vargas-Villa
- Manases González-CortazarManases González-Cortazar
- Maribel Herrera-RuizMHMaribel Herrera-Ruiz
- Sandra Victoria Ávila ReyesSRSandra Victoria Ávila Reyes
- Javier Solorza-FeriaJSJavier Solorza-Feria
- Antonio Ruperto Jiménez-AparicioAJAntonio Ruperto Jiménez-Aparicio
Open Access
Abstract
Pterygium is a corneal alteration that can cause visual impairment, which has been traditionally treated with the sap of Sedum dendroideum D.C. The pharmacological effect of a dichloromethane extract of S. dendroideum was demonstrated and implemented in a pterygium model on the healing process of corneal damage caused by phorbol esters. In mice of the ICR strain, a corneal lesion was caused by intravitreal injection of tetradecanoylphorbol acetate (TPA). The evolution of the corneal scarring process was monitored with vehicle, dexamethasone, and dichloromethane extract of S. dendroideum treatments by daily ophthalmic administration for fifteen days. The lesions were evaluated in situ with highlighted images of fluorescence of the lesions. Following treatment levels in eyeballs of IL-1α, TNF-α, and IL-10 cytokines were measured. The effective dose of TPA to produce a pterygium-like lesion was determined. The follow-up of the evolution of the scarring process allowed us to define that the treatment with S. dendroideum improved the experimental pterygium and had an immunomodulatory effect by decreasing TNF-α, IL-1α, and maintaining the level of IL-10 expression, without difference with respect to the healthy control. Traditional medical use of S. dendroideum sap to treat pterygium is fully justified by its compound composition.Keywords
Funding Information
- Instituto Mexicano del Seguro Social (99187803)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (477494)
This publication has 34 references indexed in Scilit:
- Chronic inflammatory cells and damaged limbal cells in pterygiumAfrican Health Sciences, 2013
- Crystalline keratopathy in pterigium treatment: Case reportArchivos de la Sociedad Española de Oftalmología (English Edition), 2012
- A Quantitative Approach to Scar AnalysisThe American Journal of Pathology, 2011
- Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese populationJournal of Experimental & Clinical Cancer Research, 2010
- The AP-1 transcription factor Batf controls TH17 differentiationNature, 2009
- Topical antiinflammatory effects of the ether extract from Protium kleinii and α-amyrin pentacyclic triterpeneEuropean Journal of Pharmacology, 2005
- Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinasesProgress in Retinal and Eye Research, 2004
- Identification of living oligodendrocyte developmental stages by fractal analysis of cell morphologyJournal of Neuroscience Research, 2001
- Enhancement of Mouse Sciatic Nerve Regeneration by the Long Chain Fatty Alcohol,N-HexacosanolExperimental Neurology, 1996
- Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agentsInflammation Research, 1989